WASHINGTON, Nov. 4 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Pritam International Private Limited from its Center for Drug Evaluation and Research:

* * *

Recipient: Dr. Rahul Mahajan Sr, General Manager Quality, Pritam International Private Limited, Khasra No. 138, Raipur Industrial Area Bhagwanpur, Haridwar 247667 Uttarakhand, India, rahul.mahajan@wonderproducts.co.in

I . . .

Click here for more information about our products